Lysine acetylation (Kac) by HATs (p300, CBP, GCN5) neutralises positive charge, loosens chromatin, recruits bromodomain readers (BET family). Reversed by HDACs. Drug target in oncology (SAHA, romidepsin).
Lysine acetylation (Kac) by HATs (p300, CBP, GCN5) neutralises positive charge, loosens chromatin, recruits bromodomain readers (BET family). Reversed by HDACs. Drug target in oncology (SAHA, romidepsin).